首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1469860

全球蛋白質工程市場研究報告 - 2024 年至 2032 年產業分析、規模、佔有率、成長、趨勢與預測

Global Protein Engineering Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 283 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄圖表

全球蛋白質工程市場需求預計將從2023年的20.9億美元達到2032年近87.4億美元的市場規模，2024-2032年研究期間複合年成長率為17.23%。

蛋白質工程是一個生物技術領域，專注於針對特定應用設計、修飾和最佳化蛋白質。它涉及分子建模、合理設計、定向進化和重組 DNA 技術，以創造具有所需特性和功能的蛋白質。它在醫學、農業、工業和生物技術領域有多種應用，包括開發治療性蛋白質、酵素、疫苗、生物感測器和生物材料。透過利用蛋白質結構和功能的原理，蛋白質工程能夠設計出具有改進的穩定性、活性、特異性和其他所需特性的新型分子。

市場動態

對治療各種疾病（包括癌症、自體免疫疾病和傳染病）的治療性蛋白質和生物製藥的需求不斷成長，推動了對創新蛋白質工程技術的需求，以最佳化蛋白質功能、穩定性和藥物動力學。此外，蛋白質工程技術的進步，例如合理設計、定向進化和計算建模，使得能夠開發具有增強功效、特異性和安全性的新型蛋白質療法。此外，製藥公司、學術機構和政府機構對生物技術研發的投資不斷增加，正在推動創新並推動蛋白質工程技術的商業化。

此外，蛋白質工程在治療領域之外的廣泛應用，例如用於工業生物催化的酶工程、用於生物材料和藥物傳輸系統的蛋白質設計以及用於農業生物技術的蛋白質最佳化，正在創造新的市場機會並推動成長。蛋白質工程技術在個人化醫療、診斷和再生醫學中的日益採用推動了市場的擴張。此外，公司、生物製藥公司和研究機構之間的策略合作和夥伴關係正在促進創新並加速蛋白質產品的開發和商業化。然而，對醫療設備隱私和資料安全的擔憂可能會挑戰未來幾年的市場成長。

研究報告涵蓋波特五力模型、市場吸引力分析和價值鏈分析。這些工具有助於清晰地了解行業結構並評估全球範圍內的競爭吸引力。此外，這些工具還對全球蛋白質工程市場的每個細分市場進行了包容性評估。蛋白質工程行業的成長和趨勢為這項研究提供了整體方法。

市場區隔

蛋白質工程市場報告的這一部分提供了國家和地區層面細分市場的詳細資料，從而幫助策略家確定相應產品或服務的目標人群以及即將到來的機會。

按產品分類

儀器
試劑
軟體與服務

依技術

合理的蛋白質設計
定向進化
混合方法
從頭蛋白質設計
其他

依蛋白質類型

胰島素
單株抗體
疫苗
生長因子
集落刺激因子
凝血因子
干擾素
其他

按最終用途

學術研究機構
合約研究組織（Cros）
製藥與生物技術公司

區域分析

本節涵蓋區域前景，重點介紹北美、歐洲、亞太地區、拉丁美洲以及中東和非洲蛋白質工程市場當前和未來的需求。此外，該報告重點關注所有主要地區各個應用領域的需求、估計和預測。

該研究報告還涵蓋了市場主要參與者的全面概況以及對全球競爭格局的深入了解。蛋白質工程市場的主要參與者包括安捷倫科技公司、布魯克公司、賽默飛世爾科技公司、珀金埃爾默公司、沃特世公司、Bio-Rad Laboratories、默克公司、丹納赫公司、金斯瑞生物科技公司、安進公司本節包含競爭格局的整體視圖，包括各種策略發展，例如關鍵併購、未來能力、合作夥伴關係、財務概況、合作、新產品開發、新產品發布和其他發展。

如果您有任何客製化要求，請寫信給我們。我們的研究團隊可以根據您的需求提供客製化報告。

簡介 - 市場動態
市場促進因素
市場限制
機會
產業動態
波特五力分析
市場吸引力分析
- 按產品分類的市場吸引力分析
- 按技術分類的市場吸引力分析
- 按蛋白質類型進行的市場吸引力分析
- 按最終用途分類的市場吸引力分析
- 市場吸引力分析：按地區

第 4 章：價值鏈分析

價值鏈分析
原料分析
- 原料清單
- 原料廠商清單
- 主要原物料價格走勢
潛在買家名單
行銷管道
- 直效行銷
- 間接行銷
- 行銷通路發展趨勢

第 5 章：全球蛋白質工程市場分析：依產品

概述（按產品）
歷史和預測數據
按產品分析
儀器
試劑
軟體與服務

第 6 章：全球蛋白質工程市場分析：依技術分類

依技術概述
歷史和預測數據
技術分析
合理的蛋白質設計
定向進化
混合方法
從頭蛋白質設計
其他

第 7 章：全球蛋白質工程市場分析：按蛋白質類型

依蛋白質類型概述
歷史和預測數據
依蛋白質類型分析
胰島素
單株抗體
疫苗
生長因子
集落刺激因子
凝血因子
干擾素
其他

第 8 章：全球蛋白質工程市場分析：依最終用途

按最終用途分類的概述
歷史和預測數據
按最終用途分析
學術研究機構
合約研究組織 (CRO)
製藥與生物技術公司

第 9 章：全球蛋白質工程市場分析：依地理位置

區域展望
介紹
北美銷售分析
- 概覽、歷史與預測資料銷售分析
- 北美按細分市場銷售分析
- 北美按國家銷售分析
- 美國銷售分析
- 加拿大銷售分析
- 墨西哥銷售分析
歐洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 歐洲按細分市場銷售分析
- 歐洲按國家銷售分析
- 英國銷售分析
- 法國銷售分析
- 德國銷售分析
- 義大利銷售分析
- 俄羅斯銷售分析
- 歐洲其他地區銷售分析
亞太地區銷售分析
- 概覽、歷史與預測資料銷售分析
- 亞太地區按細分市場銷售分析
- 亞太地區按國家銷售分析
- 中國銷售分析
- 印度銷售分析
- 日本銷售分析
- 韓國銷售分析
- 澳洲銷售分析
- 東南亞銷售分析
- 亞太地區其他地區銷售分析
拉丁美洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 拉丁美洲按細分市場銷售分析
- 拉丁美洲按國家銷售分析
- 巴西銷售分析
- 阿根廷銷售分析
- 秘魯銷售分析
- 智利銷售分析
- 拉丁美洲其他地區銷售分析
中東和非洲銷售分析
- 概覽、歷史與預測資料銷售分析
- 中東和非洲按細分市場銷售分析
- 中東和非洲按國家銷售分析
- 沙烏地阿拉伯銷售分析
- 阿拉伯聯合大公國銷售分析
- 以色列銷售分析
- 南非銷售分析
- 中東其他地區和非洲銷售分析

第 10 章：蛋白質工程公司的競爭格局

蛋白質工程市場競賽
夥伴關係/協作/協議
併購
新產品發布
其他發展

第 11 章：公司簡介

頂級公司市佔率分析
市場集中度
Agilent Technologies

公司簡介
公司收入
產品
最近的發展

Bruker Corp.

公司簡介
公司收入
產品
最近的發展

Thermo Fisher Scientific Inc.

公司簡介
公司收入
產品
最近的發展

PerkinElmer Inc.

公司簡介
公司收入
產品
最近的發展

Waters Corp.

公司簡介
公司收入
產品
最近的發展

Bio-Rad Laboratories

公司簡介
公司收入
產品
最近的發展

Merck KGaA

公司簡介
公司收入
產品
最近的發展

Danaher Corp.

公司簡介
公司收入
產品
最近的發展

Genscript Biotech Corp

公司簡介
公司收入
產品
最近的發展

Amgen Inc.

公司簡介
公司收入
產品
最近的發展

註 - 在公司概況中，財務詳細資料和最新進展視情況而定，或對私人公司而言可能不包括在內

簡介目錄圖表

Product Code: VMR112114269

The global demand for Protein Engineering Market is presumed to reach the market size of nearly USD 8.74 Billion by 2032 from USD 2.09 Billion in 2023 with a CAGR of 17.23% under the study period 2024 - 2032.

Protein engineering is a biotechnology field focused on designing, modifying, and optimizing proteins for specific applications. It involves molecular modeling, rational design, directed evolution, and recombinant DNA technology to create proteins with desired properties and functionalities. It has diverse applications in medicine, agriculture, industry, and biotechnology, including developing therapeutic proteins, enzymes, vaccines, biosensors, and biomaterials. By harnessing the principles of protein structure and function, protein engineering enables the design of novel molecules with improved stability, activity, specificity, and other desired characteristics.

MARKET DYNAMICS

Increasing demand for therapeutic proteins and biopharmaceuticals for treating various diseases, including cancer, autoimmune disorders, and infectious diseases, drives the need for innovative protein engineering technologies to optimize protein function, stability, and pharmacokinetics. Additionally, advancements in protein engineering techniques, such as rational design, directed evolution, and computational modeling, enable the development of novel protein-based therapeutics with enhanced efficacy, specificity, and safety profiles. Furthermore, the growing investment in biotechnology research and development by pharmaceutical companies, academic institutions, and government agencies is fueling innovation and driving the commercialization of protein engineering technologies.

Moreover, the expanding applications of protein engineering beyond therapeutics, such as enzyme engineering for industrial biocatalysis, protein design for biomaterials and drug delivery systems, and protein optimization for agricultural biotechnology, are creating new market opportunities and driving growth. The increasing adoption of protein engineering technologies in personalized medicine, diagnostics, and regenerative medicine drives market expansion. Furthermore, strategic collaborations and partnerships among companies, biopharmaceutical firms, and research institutions are fostering innovation and accelerating the development and commercialization of protein-based products. However, concerns regarding privacy and data security in medical devices may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of protein engineering. The growth and trends of protein engineering industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the protein engineering market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

Instruments
Reagents
Software & Services

By Technology

Rational Protein Design
Directed Evolution
Hybrid Approach
De Novo Protein Design
Others

By Protein Type

Insulin
Monoclonal Antibodies
Vaccines
Growth Factors
Colony Stimulating Factors
Coagulation Factors
Interferon
Others

By End-Use

Academic Research Institutes
Contract Research Organizations (Cros)
Pharmaceutical & Biotechnology Companies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Protein Engineering market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Protein Engineering market include Agilent Technologies, Bruker Corp., Thermo Fisher Scientific, Inc., PerkinElmer, Inc., Waters Corp., Bio-Rad Laboratories, Merck KGaA, Danaher Corp., Genscript Biotech Corp, Amgen Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. PROTEIN ENGINEERING - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product
- 3.7.2 Market Attractiveness Analysis By Technology
- 3.7.3 Market Attractiveness Analysis By Protein Type
- 3.7.4 Market Attractiveness Analysis By End-use
- 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PRODUCT

5.1. Overview By Product
5.2. Historical and Forecast Data
5.3. Analysis By Product
5.4. Instruments Historic and Forecast Sales By Regions
5.5. Reagents Historic and Forecast Sales By Regions
5.6. Software & Services Historic and Forecast Sales By Regions

6. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY TECHNOLOGY

6.1. Overview By Technology
6.2. Historical and Forecast Data
6.3. Analysis By Technology
6.4. Rational Protein Design Historic and Forecast Sales By Regions
6.5. Directed Evolution Historic and Forecast Sales By Regions
6.6. Hybrid Approach Historic and Forecast Sales By Regions
6.7. De Novo Protein Design Historic and Forecast Sales By Regions
6.8. Others Historic and Forecast Sales By Regions

7. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY PROTEIN TYPE

7.1. Overview By Protein Type
7.2. Historical and Forecast Data
7.3. Analysis By Protein Type
7.4. Insulin Historic and Forecast Sales By Regions
7.5. Monoclonal Antibodies Historic and Forecast Sales By Regions
7.6. Vaccines Historic and Forecast Sales By Regions
7.7. Growth Factors Historic and Forecast Sales By Regions
7.8. Colony Stimulating Factors Historic and Forecast Sales By Regions
7.9. Coagulation Factors Historic and Forecast Sales By Regions
7.10. Interferon Historic and Forecast Sales By Regions
7.11. Others Historic and Forecast Sales By Regions

8. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY END-USE

8.1. Overview By End-use
8.2. Historical and Forecast Data
8.3. Analysis By End-use
8.4. Academic Research Institutes Historic and Forecast Sales By Regions
8.5. Contract Research Organizations (CROs) Historic and Forecast Sales By Regions
8.6. Pharmaceutical & Biotechnology Companies Historic and Forecast Sales By Regions

9. GLOBAL PROTEIN ENGINEERING MARKET ANALYSIS BY GEOGRAPHY

9.1. Regional Outlook
9.2. Introduction
9.3. North America Sales Analysis
- 9.3.1 Overview, Historic and Forecast Data Sales Analysis
- 9.3.2 North America By Segment Sales Analysis
- 9.3.3 North America By Country Sales Analysis
- 9.3.4 United States Sales Analysis
- 9.3.5 Canada Sales Analysis
- 9.3.6 Mexico Sales Analysis
9.4. Europe Sales Analysis
- 9.4.1 Overview, Historic and Forecast Data Sales Analysis
- 9.4.2 Europe By Segment Sales Analysis
- 9.4.3 Europe By Country Sales Analysis
- 9.4.4 United Kingdom Sales Analysis
- 9.4.5 France Sales Analysis
- 9.4.6 Germany Sales Analysis
- 9.4.7 Italy Sales Analysis
- 9.4.8 Russia Sales Analysis
- 9.4.9 Rest Of Europe Sales Analysis
9.5. Asia Pacific Sales Analysis
- 9.5.1 Overview, Historic and Forecast Data Sales Analysis
- 9.5.2 Asia Pacific By Segment Sales Analysis
- 9.5.3 Asia Pacific By Country Sales Analysis
- 9.5.4 China Sales Analysis
- 9.5.5 India Sales Analysis
- 9.5.6 Japan Sales Analysis
- 9.5.7 South Korea Sales Analysis
- 9.5.8 Australia Sales Analysis
- 9.5.9 South East Asia Sales Analysis
- 9.5.10 Rest Of Asia Pacific Sales Analysis
9.6. Latin America Sales Analysis
- 9.6.1 Overview, Historic and Forecast Data Sales Analysis
- 9.6.2 Latin America By Segment Sales Analysis
- 9.6.3 Latin America By Country Sales Analysis
- 9.6.4 Brazil Sales Analysis
- 9.6.5 Argentina Sales Analysis
- 9.6.6 Peru Sales Analysis
- 9.6.7 Chile Sales Analysis
- 9.6.8 Rest of Latin America Sales Analysis
9.7. Middle East & Africa Sales Analysis
- 9.7.1 Overview, Historic and Forecast Data Sales Analysis
- 9.7.2 Middle East & Africa By Segment Sales Analysis
- 9.7.3 Middle East & Africa By Country Sales Analysis
- 9.7.4 Saudi Arabia Sales Analysis
- 9.7.5 UAE Sales Analysis
- 9.7.6 Israel Sales Analysis
- 9.7.7 South Africa Sales Analysis
- 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE PROTEIN ENGINEERING COMPANIES

10.1. Protein Engineering Market Competition
10.2. Partnership/Collaboration/Agreement
10.3. Merger And Acquisitions
10.4. New Product Launch
10.5. Other Developments

11. COMPANY PROFILES OF PROTEIN ENGINEERING INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Market Concentration Rate
11.3. Agilent Technologies
- 11.3.1 Company Overview
- 11.3.2 Company Revenue
- 11.3.3 Products
- 11.3.4 Recent Developments
11.4. Bruker Corp.
- 11.4.1 Company Overview
- 11.4.2 Company Revenue
- 11.4.3 Products
- 11.4.4 Recent Developments
11.5. Thermo Fisher Scientific Inc.
- 11.5.1 Company Overview
- 11.5.2 Company Revenue
- 11.5.3 Products
- 11.5.4 Recent Developments
11.6. PerkinElmer Inc.
- 11.6.1 Company Overview
- 11.6.2 Company Revenue
- 11.6.3 Products
- 11.6.4 Recent Developments
11.7. Waters Corp.
- 11.7.1 Company Overview
- 11.7.2 Company Revenue
- 11.7.3 Products
- 11.7.4 Recent Developments
11.8. Bio-Rad Laboratories
- 11.8.1 Company Overview
- 11.8.2 Company Revenue
- 11.8.3 Products
- 11.8.4 Recent Developments
11.9. Merck KGaA
- 11.9.1 Company Overview
- 11.9.2 Company Revenue
- 11.9.3 Products
- 11.9.4 Recent Developments
11.10. Danaher Corp.
- 11.10.1 Company Overview
- 11.10.2 Company Revenue
- 11.10.3 Products
- 11.10.4 Recent Developments
11.11. Genscript Biotech Corp
- 11.11.1 Company Overview
- 11.11.2 Company Revenue
- 11.11.3 Products
- 11.11.4 Recent Developments
11.12. Amgen Inc.
- 11.12.1 Company Overview
- 11.12.2 Company Revenue
- 11.12.3 Products
- 11.12.4 Recent Developments